Loading patent…
AssigneeNitto Denko Corporation
InventorsYoshiro Niitsu, Rishu Takimoto, Joseph E. Payne, John A. Gaudette, Zheng Hou, Victor Knopov, Richard P. Witte, Mohammad Ahmadian, Loren A. Perelman, Yasunobu Tanaka, Violetta Akopian
Estimating the term…
Disclosed are a novel therapeutic agent and a novel treatment method for cancer. Specifically disclosed are: a targeting agent for a cell selected from the group consisting of a cancer cell and a cancer-associated fibroblast, which comprises a retinoid and/or derivative thereof; a substance delivery carrier for the cell, which comprises the targeting agent; an anti-cancer composition utilizing the targeting agent or the carrier; an anticancer-associated fibroblast composition; and a method for treatment of cancer.
A targeting agent to a cancer cell, the targeting agent comprising one or more compounds selected from the group consisting of a retinoid, (retinoid)m-linker-(retinoid)n and (lipid)m,linker-(retinoid)n, wherein m and n are independently 0, 1, 2, or 3, except that m and n are not both zero;
A targeting agent to a cancer-associated fibroblast, the targeting agent comprising one or more compounds selected from the group consisting of a retinoid, (retinoid)m-linker-(retinoid)m and (lipid)m-linker-(retinoid)n, wherein m and n are independently 0, 1, 2, or 3, except that m and n are not both zero;
Dependencies are inferred from the claim text.